Evidity Health Capital — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Standard MolecularApr 2018
BiotechCambridge, US
Nathaniel Weiss(Executive Officer, Director)David Artz(Director)Andrew Smith(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.